Novavax SG&A Expense (Semi Annual) Insights

Novavax, Inc. (NVAX)

7.70 -0.32 (-3.99%) USD | NASDAQ | Apr 02, 16:00

7.81 +0.11 (+1.43%) Pre-Market: 08:22

View SG&A Expense (Semi Annual) for NVAX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (Semi Annual) Chart

Start Trial

View Historical Data

Start Trial

View SG&A Expense (Semi Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View SG&A Expense (Semi Annual) Benchmarks

Start Trial

Merck & Co., Inc.	--
Pfizer Inc.	--
Moderna, Inc.	--
Intellia Therapeutics, Inc.	--
Recursion Pharmaceuticals, Inc.	--